NKTR filings
Corporate insider profile
Jonathan Zalevsky Filing Activity
Latest reported as Chief R&D Officer of NEKTAR THERAPEUTICS (NKTR).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$760,306.75
- Latest transaction
- Aug 18, 2026
Affiliated corporations
Reported company relationships
Transaction history
